A study led by First Health Pharmaceuticals B.V. (FHPBV) and the Italian Institute of oncological research and prevention (ISPRO), together with the University of Siena…
DDX3 RNA Helicase
The spread of novel coronavirus in China has been confirmed by Chinese authorities. After more than 290 sickened people and presumably more than 1700 infected…
First Health Pharmaceuticals is going to participate in the 17th European AIDS Conference which will be held in Basel, Switzerland, November 6-9, 2019. The European…
First Health Pharmaceuticals is proud to announce a new multi center public-private collaboration on HIV cure research in the Netherlands. The project called “Genezingvooriedereenanders” which…
When it comes to the latest news on HIV treatment, there are some very hopeful research results about newly developed drugs and therapies, but most…
Global HIV & AIDS figures According to the latest global statistics on the status of AIDS epidemic, in 2016, 36.7 million people were living with…
Today the final agreement was signed through which biotech company First Health Pharmaceuticals transferred large part of its pipeline of highly active antivirus agents concerning…
Our research clearly points towards an important role of DDX3 overexpression in cancer. We have already had very positive test results in breast cancer but…
The DDX3 RNA Helicase is a known host factor for a wide array of viruses of which many are already investigated by our group. Some…
Today the famous Italian playwright and Nobel Prize for literature winner Dario Fo sadly passed away. Up to the very end he was personally engaged…